| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |